Biochips Markets by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Size, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 – 2021
A Biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that can perform hundreds or thousands of simultaneous biochemical reactions in order to achieve higher throughput and speed. Biochips help researchers to quickly see large number of biological analytics and are used in a range of research applications within the biotechnology sector, including pharmaceuticals, proteomics and genomics. Biochips are also used in analysis of organic molecules associated with living organisms and helps in identifying gene sequences, airborne toxins, environmental pollutants and other biochemical constituents. Although biochips have been developed and commercialized in mid eighties but the market has transformed in the starting of last decade. The global biochips market is expected to grow approximately at anannual growth rate (CAGR) of 18% (2015-2021).
Presently the biochips market is undergoing rapid expansion with the discovery of new applications and the development of existing technologies. The key driving forces for the market of biochips are: growth in personalized medicine market, increase in government spending/ private investment in healthcare budgets and R&D respectively, rising case of lifestyle related diseases and so on. Various factors such as less accuracy of biochips that may lead to wrong analysis, low rate of translation of discoveries in drugs, medical devices and protein biomarkers, low acceptance due to high cost and availability of alternative technologies are restraining the growth of biochips market.
Research and development is considered to be significant approach to bring more insight to human genome project. Globally, the inclination towards personalized medicine is increasing as a result biochips market has huge scope in future. Biochips market is collaborated by the significant inflows of government and private funds. These funds raised by the biochips companies are being invested in further R&D process by which the companies can come up with various technologically advance and innovative technologies. Biochips market is considered to be very promising and various innovative technologies with economic reagents are expected to come in near future. APAC region is the most emerging market and has huge scope in near future; as a result various biochips companies are focusing on APAC countries such as India, China, Japan and Korea.
The report has covered the prevalence of life style oriented diseases such as cancer, diabetes, CVD and other heart diseases in the parametric analysis. The rising life style oriented diseases are also covered with global and regional perspectives. There is global adoption of diagnostics through biochips in research centers which is also a significant parameter covered in the report. Growing healthcare expenditure across geographiesis favorable for the biochips market since diagnosis is expensive.
The global biochips market is segmented on the basis of applications, types, and by end users. In applications the market is segmented by DNA micro array market, lab-on-chip (LOC) market, protein micro array market and other array market. On the basis of types the market is segmented into protein microarray market and other array market. By end user the market is segmented into R&D tools, drug discovery and tools, diagnostic centers and sequencing and others. Among all segments the DNA microarrays represent the largest segment of biochips market and will continue to be the largest contributor during the forecasted period However, this segment will expected to be closely followed by lab-on-chip in due to its wide applications and increased adoption by various biotechnology, pharmaceutical companies, and research laboratories and the third largest segment will be protein microarrays due to advances in the fields of genomics and proteomics and improvements in the field of recombinant proteins.
Development in genomics and proteomics are considered to be significant steps for the growth and development of biochips market. The rise in incidence and prevalence rate in cancer are giving rise to diagnostic and drug discovery market in biochips market. However, DNA micro array market is expected to contribute highest among all the segments of biochips market. Lab on a chip is the emerging market with the advancement and development of genomics and proteomics in biochips market.Moreover, the report also includes the end user analysis of biochips market. It includes the research and development institutes, drug discovery and development centers and so on.
Geographically the market is segmented into North America (US, Canada), Europe (UK, Italy, Spain, France, Germany, RoE), Asia-Pacific (India, Japan, Australia, China, Korea, RoAPAC) and Rest of World (Latin America, MENA and Africa). Presently North America dominates the global biochips market due to large number of aging population and broad technical applications of biochips followed by Europe and Asia-Pacific. Asia-Pacific market is expected togrow in future due to growing economies like India and China.The key players in global biochips market are Agilent technologies AffymetricInc, Gene system Inc, Agendia BVInc, Customarray inc, Digital genomics inc, Bio chain institute Inc, Biomerieux SA , Bio-rad laboratories inc, Cepheid Inc, Caliper life sciences inc, Cybrdi inc, EMD Millipore, Elim Biopharmaceuticals, Falcon Genomics, Genalyte and so on.
1. Introduction
1.1. Executive summary
1.2. Estimation methodology
2. Market overview
2.1. Market definition and scope
2.2. Key findings
2.3. Parametric analysis
2.3.1. Prevalence of life style oriented diseases
2.3.2. Incidence and prevalence rate of cancer
2.3.3. Adoption of biochips in major hospitals and clinics across geographies
2.3.4. Adoption of diagnostics through biochips in research centers
2.3.5. Growing healthcare expenditure across geographies
2.4. Key market insights
2.4.1. Top 3 emerging countries
2.4.2. Top 3 revenue generating segments
2.4.3. Top growing markets and emerging trends
2.4.4. R&D scenario in biochips market
2.4.4.1. Human genome project
2.4.4.2. Silicon technology for electronic biochip
2.5. Competitive intelligence
2.5.1. Market share analysis
2.5.2. Top winning strategies
2.5.3. Case studies: top competitive moves
2.6. Value chain analysis
2.7. Key buying criteria
2.8. Strategic recommendation
2.9. Strategic conclusions
3. Market determinants
3.1. Market drivers
3.1.1. Global growth in personalized medicines
3.1.2. Global increase in government and private funding
3.1.3. Increase in cancer diagnostics and treatment
3.1.4. Innovation giving rise to biochips market
3.1.5. Global increase in life style oriented disease and other new diseases
3.1.6. Technological advancement
3.1.7. Global increase in healthcare expenditure
3.1.8. Increase in r&d from major players
3.2. Market restraints
3.2.1. Less accuracy of biochips may lead to wrong analysis
3.2.2. Low rate of translation of discoveries in drugs, medical devices and protein biomarkers
3.3. Market challenges
3.3.1. High expertise required for the diagnosis through biochips
3.3.2. Creating awareness for increasing adoption of biochip market
3.4. Market opportunities
3.4.1. Innovative detection technology with economic reagents to come in near future
3.4.2. Untapped APAC region has huge scope for ophthalmology drug and device market
3.4.3. Increase in adoption of lab-on-chip technology
4. Sector Analysis
4.1. Parent market
4.2. Sub-segment market
4.3. Alternative market
5. Market Segmentation
5.1. Global biochips market by application
5.1.1. Global DNA micro array market by application, 2014-2021,($ millions)
5.1.1.1. Global gene expression market, 2014-2021,($ millions)
5.1.1.2. Global SNP genotyping market, 2014-2021,($ millions)
5.1.1.3. Global Cancer diagnosis and treatment market, 2014-2021,($ millions)
5.1.1.4. Global Genomics, 2014-2021,($ millions)
5.1.1.5. Global drug discovery market , 2014-2021,($ millions)
5.1.1.6. Global other DNA micro array market, 2014-2021,($ millions)
5.1.2. Global Lab on a chip market by application , 2014-2021,($ millions)
5.1.2.1. Global Genomics market s, 2014-2021,($ millions)
5.1.2.2. Global proteomics market, 2014-2021,($ millions)
5.1.2.3. Global drug discovery, 2014-2021 market,($ millions)
5.1.2.4. Global diagnostics market, 2014-2021,($ millions)
5.1.2.5. Global other lab on chip market, 2014-2021,($ millions)
5.1.3. Global protein microarray market by application , 2014-2021,($ millions)
5.1.3.1. Global expression profiling market , 2014-2021,($ millions)
5.1.3.2. Global proteomics market, 2014-2021,($ millions)
5.1.3.3. Global high throughput screening market, 2014-2021,($ millions)
5.1.3.4. Global diagnostic market, 2014-2021,($ millions)
5.1.3.5. Global drug discovery market, 2014-2021,($ millions)
5.1.3.6. Global other protein microarray market, 2014-2021,($ millions)
5.1.4. Global other array market by application, 2014-2021,($ millions)
5.1.4.1. Global expression profiling market, 2014-2021,($ millions)
5.1.4.2. Global cancer diagnostic market , 2014-2021,($ millions)
5.1.4.3. Global toxico genomics market, 2014-2021,($ millions)
5.1.4.4. Global genomics market, 2014-2021,($ millions)
5.1.4.5. Global drugs discovery market, 2014-2021,($ millions)
5.1.4.6. Global other array market, 2014-2021,($ millions)
5.2. Global biochip market by type, 2014-2021,($ millions)
5.2.1. Global protein microarray market by types, 2014-2021,($ millions)
5.2.1.1. Global expressional protein microarray market , 2014-2021,($ millions)
5.2.1.1.1. Global functional protein microarray market, 2014-2021,($ millions)
5.2.1.1.2. Global reverse phase protein microarray market, 2014-2021,($ millions)
5.2.2. Global other array market by types, 2014-2021,($ millions)
5.2.2.1. Global cell array market , 2014-2021,($ millions)
5.2.2.2. Global tissue array market , 2014-2021,($ millions)
5.2.2.2.1. Global FFPE arrays market , 2014-2021,($ millions)
5.2.2.2.2. Global frozen arrays market , 2014-2021,($ millions)
5.3. Global biochip market by end user, 2014-2021,($ millions)
5.3.1. Research and development tools
5.3.2. Drug discovery and development
5.3.3. Diagnostic centers
5.3.4. Sequencing and other
6. Competitive Landscape
6.1. Market share
6.2. Strategy – An analysis across tiers
7. Geographical analysis
7.1. North America market, 2014-2021,($millions)
7.1.1. United States (U.S.) market, 2014-2021,($millions)
7.1.2. Canada market, 2014-2021,($millions)
7.2. Europe market, 2014-2021,($millions)
7.2.1. United Kingdom (UK) market, 2014-2021,($millions)
7.2.2. France market, 2014-2021,($millions)
7.2.3. Germany market, 2014-2021,($millions)
7.2.4. Spain market, 2014-2021,($millions)
7.2.5. Italy market, 2014-2021,($millions)
7.2.6. RoE market, 2014-2021,($millions)
7.3. Asia Pacific market, 2014-2021,($millions)
7.3.1. India market, 2014-2021,($millions)
7.3.2. China market, 2014-2021,($millions)
7.3.3. Japan market, 2014-2021,($millions)
7.3.4. Korea market, 2014-2021,($millions)
7.3.5. Australia market, 2014-2021,($millions)
7.3.6. RoAPAC market, 2014-2021,($millions)
7.4. Rest of the world market, 2014-2021,($millions)
7.4.1. Latin America market, 2014-2021,($millions)
7.4.2. MENA market, 2014-2021,($millions)
7.4.3. Africa market, 2014-2021,($millions)
8. Company Profiling: - (Over, SCOT analysis, strategic review)
8.1. Agilent technologies
8.2. Affymetrix inc
8.3. Gene system inc
8.4. Agendia BV inc
8.5. Customarray inc
8.6. Digital genomics inc
8.7. Bio chain institute Inc
8.8. Biomerieux SA
8.9. Bio-rad laboratories inc
8.10. Cepheid Inc
8.11. Caliper life sciences inc
8.12. Cybrdi inc
8.13. EMD Millipore
8.14. Elim Biopharmaceuticals
8.15. Falcon Genomics.
8.16. Genalyte
8.17. Oxford gene technology
8.18. Wafergen biosystems inc
8.19. Predictive biosciences
8.20. Fluidigm corp
8.21. Gamida for life group
8.22. Illumina Inc
8.23. Life technologies corp
8.24. Origene technologies Inc
8.25. Perkinelmer inc
8.26. Roche nimblegen inc
8.27. Sequenom
8.28. Sigma aldrich corp
8.29. Imgenex
8.30. ISU ABXIS co. ltd
8.31. Quantalife inc
List of tables:
1. Global biochips market by application, 2014-2021, ($ millions)
2. Global DNA micro array market by application, 2014-2021, ($ millions)
3. Global gene expression market, 2014-2021,($ millions)
4. Global SNP genotyping market, 2014-2021,($ millions)
5. Global Cancer diagnosis and treatment market, 2014-2021,($ millions)
6. Global Genomics, 2014-2021,($ millions)
7. Global drug discovery market , 2014-2021,($ millions)
8. Global other dna micro array market, 2014-2021,($ millions)
9. Global Lab on a chip market by application , 2014-2021,($ millions)
10. Global Genomics market s, 2014-2021,($ millions)
11. Global proteomics market, 2014-2021,($ millions)
12. Global drug discovery, 2014-2021 market,($ millions)
13. Global diagnostics market, 2014-2021,($ millions)
14. Global other lab on chip market, 2014-2021,($ millions)
15. Global protein microarray market by application , 2014-2021,($ millions)
16. Global expression profiling market , 2014-2021,($ millions)
17. Global proteomics market, 2014-2021,($ millions)
18. Global high throughput screening market, 2014-2021,($ millions)
19. Global diagnostic market, 2014-2021,($ millions)
20. Global drug discovery market, 2014-2021,($ millions)
21. Global other protein microarray market, 2014-2021,($ millions)
22. Global other array market by application, 2014-2021,($ millions)
23. Global expression profiling market, 2014-2021,($ millions)
24. Global cancer diagnostic market , 2014-2021,($ millions)
25. Global toxico genomics market, 2014-2021,($ millions)
26. Global genomics market, 2014-2021,($ millions)
27. Global drugs discovery market, 2014-2021,($ millions)
28. Global other array market, 2014-2021,($ millions)
29. Global biochip market by type, 2014-2021,($ millions)
30. Global protein microarray market by types, 2014-2021,($ millions)
31. Global expressional protein microarray market , 2014-2021,($ millions)
32. Global functional protein microarray market, 2014-2021,($ millions)
33. Global reverse phase protein microarray market, 2014-2021,($ millions)
34. Global other array market by types, 2014-2021,($ millions)
35. Global cell array market , 2014-2021,($ millions)
36. Global tissue array market , 2014-2021,($ millions)
37. Global FFPE arrays market , 2014-2021,($ millions)
38. Global frozen arrays market , 2014-2021,($ millions)
39. Global biochips market by end user, 2014-2021,($ millions)
40. Global research and development tools market, 2014-2021,($ millions)
41. Global drug discovery and development market, 2014-2021,($ millions)
42. Global diagnostic centers market, 2014-2021,($ millions)
43. Global sequencing and other market, 2014-2021,($ millions)
